Market Overview

Quality Systems, Inc. Reports Fiscal 2019 First Quarter Results


Quality Systems, Inc. (QSII), known to its clients as NextGen
Healthcare, announced today its fiscal 2019 first quarter ended June 30,
2018 operating results.

"We are pleased with continuing progress executing our plan, as
illustrated by our team's delivery of another solid performance in the
first quarter of fiscal 2019 with revenue and EPS in-line with our
expectations. Most importantly, we saw continued momentum in quarterly
bookings with first quarter bookings up 23% year over year, which marks
our second consecutive quarter of growth. Based on these results, we
remain confident in the current year guidance and committed to our
multi-year growth targets," commented Rusty Frantz, president and chief
executive officer of NextGen Healthcare.

Fiscal 2019 First Quarter Highlights

As a result of the adoption of Accounting Standards Update No. 2014-09, Revenue
from Contracts with Customers: Topic 606
("ASC 606"), the GAAP
comparisons below compare fiscal 2019 first quarter results under ASC
606 to the fiscal 2018 first quarter results under ASC 605. A
reconciliation of fiscal 2019 first quarter results from ASC 606 to ASC
605 can be found in the tables at the end of the press release.

On a GAAP basis, revenue for the fiscal 2019 first quarter of $133.2
million compared to $130.9 million a year-ago. On a pro forma basis
under ASC 605, revenue for the fiscal 2019 first quarter was also $133.2

On a GAAP basis, net income for the fiscal 2019 first quarter was $2.6
million, compared with net income of $3.9 million in the fiscal 2018
first quarter. On a pro forma basis under ASC 605, net income for the
fiscal 2019 first quarter was $1.7 million.

On a GAAP basis, fully diluted net income per share was $0.04 in the
fiscal 2019 first quarter compared with earnings per share of $0.06 for
the same period a year ago. On a non-GAAP basis, fully diluted earnings
per share for the fiscal 2019 first quarter was $0.19 versus $0.17
reported in the first quarter a year ago. On a pro forma non-GAAP basis
under ASC 605, fully diluted earnings per share for the fiscal 2019
first quarter was $0.18.

Fiscal 2019 Financial Outlook

The company is reiterating its outlook for fiscal 2019 and expects:

  • Revenue of between $532 million and $548 million
  • Non-GAAP EPS of between $0.70 and $0.78

Conference Call Information

NextGen Healthcare will host a conference call to discuss its fiscal
2019 first quarter results on Tuesday, July 31, 2018 at 5:00 PM ET (2:00
PM PT). Shareholders and interested participants may listen to a live
broadcast of the conference call by dialing 866-750-8947 or 720-405-1352
for international callers, and referencing participant code 2995586
approximately 15 minutes prior to the call. A live webcast of the
conference call will be available on the investor relations section of
the company's web site and an audio file of the call will also be
archived for 90 days at
After the conference call, a replay will be available until August 14,
2018 and can be accessed by dialing 800-585-8367 or 404-537-3406 for
international callers, and referencing participant code 2995586.

2018 Analyst Day Meeting

The Company will host an Analyst Day Meeting on Friday, September 7,
2018 at 9:00 AM ET in New York, NY. To RSVP or for further information,
please contact Jordan Kohnstam at
or 443-450-4189.

About Quality Systems, Inc.

Quality Systems, Inc., known to its clients as NextGen Healthcare,
provides a range of software, services, and analytics solutions to
medical and dental group practices. The company's portfolio delivers
foundational capabilities to empower physician success, enrich the
patient care experience, and enable the transition to value-based
healthcare. Visit
for additional information.


This news release may contain forward-looking statements within the
meaning of the federal securities laws, including but not limited to,
statements regarding future events, developments in the healthcare
sector and regulatory framework, the Company's future performance, as
well as management's expectations, beliefs, intentions, plans, estimates
or projections relating to the future (including, without limitation,
statements concerning revenue, net income, and earnings per share).
Risks and uncertainties exist that may cause the results to differ
materially from those set forth in these forward-looking statements.
Factors that could cause the anticipated results to differ from those
described in the forward-looking statements and additional risks and
uncertainties are set forth in Part I, Item A of our most recent Annual
Report on Form 10-K and subsequently filed Quarterly Reports on Form
10-Q, including but not limited to: the volume and timing of systems
sales and installations; length of sales cycles and the installation
process; the possibility that products will not achieve or sustain
market acceptance; seasonal patterns of sales and customer buying
behavior; impact of incentive payments under The American Recovery and
Reinvestment Act on sales and the ability of the Company to meet
continued certification requirements; uncertainties related to the
future impact of U.S. tax reform; the impact of governmental and
regulatory agency investigations; the development by competitors of new
or superior technologies; the timing, cost and success or failure of new
product and service introductions, development and product upgrade
releases; undetected errors or bugs in software; product liability;
changing economic, political or regulatory influences in the health-care
industry; changes in product-pricing policies; availability of
third-party products and components; competitive pressures including
product offerings, pricing and promotional activities; the Company's
ability or inability to attract and retain qualified personnel; possible
regulation of the Company's software by the U.S. Food and Drug
Administration; changes of accounting estimates and assumptions used to
prepare the prior periods' financial statements; disruptions caused by
acquisitions of companies, products, or technologies; and general
economic conditions. A significant portion of the Company's quarterly
sales of software product licenses and computer hardware is concluded in
the last month of a fiscal quarter, generally with a concentration of
such revenues earned in the final ten business days of that month. Due
to these and other factors, the Company's revenues and operating results
are very difficult to forecast. A major portion of the Company's costs
and expenses, such as personnel and facilities, are of a fixed nature
and, accordingly, a shortfall or decline in quarterly and/or annual
revenues typically results in lower profitability or losses. As a
result, comparison of the Company's period-to-period financial
performance is not necessarily meaningful and should not be relied upon
as an indicator of future performance. These forward-looking statements
speak only as of the date hereof. The Company undertakes no obligation
to publicly update any forward-looking statements, whether as a result
of new information, future events or otherwise.


This news release contains certain non-GAAP (Generally Accepted
Accounting Principles) financial measures, which are provided only as
supplemental information. Investors should consider these non-GAAP
financial measures only in conjunction with the comparable GAAP
financial measures. These non-GAAP measures are not in accordance with
or a substitute for U.S. GAAP. Pursuant to the requirements of
Regulation G, the Company has provided a reconciliation of non-GAAP
financial measures to the most directly comparable financial measure in
the accompanying financial tables. Other companies may calculate
non-GAAP measures differently than Quality Systems, which limits
comparability between companies. The Company believes that its
presentation of non-GAAP diluted earnings per share provides useful
supplemental information to investors and management regarding the
Company's financial condition and results. The presentation of non-GAAP
financial information is not intended to be considered in isolation or
as a substitute for, or superior to, financial information prepared and
presented in accordance with GAAP. The Company calculates non-GAAP
diluted earnings per share by excluding net acquisition costs,
amortization of acquired intangible assets, amortization of deferred
debt issuance costs, restructuring costs, net securities litigation
defense costs and settlement, share-based compensation, and other
non-run-rate expenses from GAAP income before provision for income
taxes. The Company utilizes a normalized non-GAAP tax rate to provide
better consistency across the interim reporting periods within a given
fiscal year by eliminating the effects of non-recurring and
period-specific items, which can vary in size and frequency, and which
are not necessarily reflective of the Company's longer-term operations.

The normalized non-GAAP tax rate applied to fiscal year 2019 was
22.0%, compared to 30.5% for fiscal year 2018, which was updated as a
result of the enactment of the new tax reform legislation on December
22, 2017. The determination of this rate is based on the consideration
of both historic and projected financial results. The Company may adjust
its non-GAAP tax rate as additional information becomes available and in
conjunction with any other significant events occur that may materially
affect this rate, such as merger and acquisition activity, changes in
business outlook, or other changes in expectations regarding tax

The Company's future period guidance in this release includes
adjustments for items not indicative of the Company's core operations.
Such adjustments are generally expected to be of a nature similar to
those adjustments applied to the Company's historic GAAP financial
results in the determination of the Company's non-GAAP diluted earnings
per share. Such adjustments, however, may be affected by changes in
ongoing assumptions and judgments as to the items that are excluded in
the calculation of non-GAAP adjusted net income and adjusted diluted
earnings per share, as described in this release. The exact amount and
probable significance of these adjustments, including net acquisition
costs, net securities litigation defense costs, and other non-run-rate
expenses, are not currently determinable without unreasonable efforts,
but may be significant. These items cannot be reliably quantified or
forecasted due to the combination of their historic and expected
variability. It is therefore not practicable to reconcile this non-GAAP
guidance to the most comparable GAAP measures.




(In thousands, except per share data)


Three Months Ended June 30,
2018   2017
Recurring $ 120,007 $ 119,178
Software, hardware, and other non-recurring   13,193   11,744
Total revenues 133,200 130,922
Cost of revenue:
Recurring 48,153 48,458
Software, hardware, and other non-recurring 7,154 6,040
Amortization of capitalized software costs and acquired intangible
  6,544   4,671
Total cost of revenue   61,851   59,169
Gross profit 71,349 71,753
Operating expenses:
Selling, general and administrative 44,636 42,977
Research and development costs, net 22,128 19,989
View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at